相关实验视频
Updated: Jun 6, 2025

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.8K
微RNA在乳腺癌发育和进展中的作用:当前的研究
Sachin Kumar1, Abhishek Ranga1
1Department of Pharmacology, DIPSAR, Delhi Pharmaceutical Sciences and Research University, New Delhi, India.
BioFactors (Oxford, England)
|November 27, 2024
概括
微RNAs (miRNAs) 是乳腺癌发展和进展的关键调节者. 研究强调了它们作为诊断生物标志物和改善患者治疗结果的治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 乳腺癌是全球癌症相关死亡的主要原因,其特点是复杂性和异质性.
- 微RNAs (miRNAs),小型非编码RNAs,在调节基因表达方面发挥着关键作用,影响乳腺癌进展中的关键细胞过程.
研究的目的:
- 提供关于miRNAs在乳腺癌中的作用的当前研究的全面概述.
- 讨论miRNAs作为诊断生物标记物和乳腺癌治疗剂的潜力.
主要方法:
- 审查关于miRNA参与乳腺癌亚型和分子特征的现有文献.
- 对识别失调miRNA及其调节机制的研究进行分析.
- 探索基于miRNA的治疗方法的临床前数据 (对抗体,miRNA模拟物).
主要成果:
- 在乳腺癌中,miRNAs显著失调,影响了增殖,分化和亡.
- 特定的miRNA显示出作为诊断和预后生物标志物的潜力.
- 临床前研究表明,基于miRNA的疗法在抑制瘤生长和转移方面具有有效性.
结论:
- miRNAs在乳腺癌研究中至关重要,提供了创新的诊断和治疗可能性.
- 进一步了解miRNA失调对于临床翻译至关重要.
- 人工智能和One Health方法是乳腺癌miRNA研究的新兴领域.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K

